Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3330029285 ISBN 13: 9783330029286
Librería: Revaluation Books, Exeter, Reino Unido
EUR 62,28
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Brand New. 56 pages. 8.66x5.91x0.13 inches. In Stock.
Idioma: Inglés
Publicado por LAP Lambert Academic Publishing, 2017
ISBN 10: 3330029285 ISBN 13: 9783330029286
Librería: preigu, Osnabrück, Alemania
EUR 33,25
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Recent Advancement in Diagnosis and Therapy of Ovarian Cancer | New insights in the pathophysiology, diagnosis, prevention and management of Ovarian Carcinoma | Kuwali Das | Taschenbuch | 56 S. | Englisch | 2017 | LAP Lambert Academic Publishing | EAN 9783330029286 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3330029285 ISBN 13: 9783330029286
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 131,31
Cantidad disponible: 1 disponibles
Añadir al carritopaperback. Condición: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Idioma: Inglés
Publicado por LAP Lambert Academic Publishing Jan 2017, 2017
ISBN 10: 3330029285 ISBN 13: 9783330029286
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 35,90
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Despite advances in medicine, ovarian cancer remains the deadliest of the gynecological malignancies. Learning that someone has ovarian cancer is overwhelming. This book includes many medical words which are used to describe cancer, diagnostic tests and treatments, which a patient or their family member likely to hear from doctors. This book will also help you talk to your doctors and self understanding of what doctors suggest for treatment. The author goal is to help someone get the best care. This book is a unique attempt to best describe cancer basics-how ovarian cancer starts, how it spreads and the symptoms it may cause. This book also describes the tests doctors used to find and confirm ovarian cancer and plan their treatment. This is a compilation of full range of information for improved prognosis in ovarian carcinoma, molecular mechanisms of its etiology, chemotherapy and emerging biologic agents that present a therapeutic option for patients with different stages of ovarian cancer with new targeted biologic agents and emerging therapies that hold great promise for improving the outcome of ovarian cancer. 56 pp. Englisch.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2017
ISBN 10: 3330029285 ISBN 13: 9783330029286
Librería: moluna, Greven, Alemania
EUR 31,27
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Nath BipulDr. Bipul Nath, Ph.D, M.Pharm, prof. at Department of Pharmaceutics, Girijananda Chowdhury Institute of Pharmaceutical Science presently, affiliated to Assam Science and Technology University, Guwahati, Kamrup, Assam, India.
Idioma: Inglés
Publicado por LAP Lambert Academic Publishing Jan 2017, 2017
ISBN 10: 3330029285 ISBN 13: 9783330029286
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 35,90
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Despite advances in medicine, ovarian cancer remains the deadliest of the gynecological malignancies. Learning that someone has ovarian cancer is overwhelming. This book includes many medical words which are used to describe cancer, diagnostic tests and treatments, which a patient or their family member likely to hear from doctors. This book will also help you talk to your doctors and self understanding of what doctors suggest for treatment. The author goal is to help someone get the best care. This book is a unique attempt to best describe cancer basics-how ovarian cancer starts, how it spreads and the symptoms it may cause. This book also describes the tests doctors used to find and confirm ovarian cancer and plan their treatment. This is a compilation of full range of information for improved prognosis in ovarian carcinoma, molecular mechanisms of its etiology, chemotherapy and emerging biologic agents that present a therapeutic option for patients with different stages of ovarian cancer with new targeted biologic agents and emerging therapies that hold great promise for improving the outcome of ovarian cancer.Books on Demand GmbH, Überseering 33, 22297 Hamburg 56 pp. Englisch.
Idioma: Inglés
Publicado por LAP Lambert Academic Publishing, 2017
ISBN 10: 3330029285 ISBN 13: 9783330029286
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 37,20
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Despite advances in medicine, ovarian cancer remains the deadliest of the gynecological malignancies. Learning that someone has ovarian cancer is overwhelming. This book includes many medical words which are used to describe cancer, diagnostic tests and treatments, which a patient or their family member likely to hear from doctors. This book will also help you talk to your doctors and self understanding of what doctors suggest for treatment. The author goal is to help someone get the best care. This book is a unique attempt to best describe cancer basics-how ovarian cancer starts, how it spreads and the symptoms it may cause. This book also describes the tests doctors used to find and confirm ovarian cancer and plan their treatment. This is a compilation of full range of information for improved prognosis in ovarian carcinoma, molecular mechanisms of its etiology, chemotherapy and emerging biologic agents that present a therapeutic option for patients with different stages of ovarian cancer with new targeted biologic agents and emerging therapies that hold great promise for improving the outcome of ovarian cancer.